AK

Ankit Khaneja

Active Director Director DIN 09274140
DIN 09274140 First appointment Aug 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Ankit Khaneja

Data last updated:

Ankit Khaneja is a Director at Medxen Biotech Private Limited (since 2021). The company operates in Chemicals. Medxen Biotech Private Limited reported revenue of ₹23.7 Lakh (FY 2025).

DIN 09274140
Primary Designation Director
Industry Chemicals
First Appointment 09 Aug 2021
Oldest Company Age 5 yrs
Largest company Medxen Biotech Private Limited · ₹23.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medxen Biotech Private Limited U24230DL2021PTC384917
Director09 Aug 20212021₹23.7 Lakh (FY 2025)Active

Board colleagues of Ankit Khaneja

NameDINCompanyDesignation
Sakshi Arora09274141Medxen Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medxen Biotech Private Limited
Premium access

Shareholding and investment profile for Ankit Khaneja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankit Khaneja

Ankit Khaneja currently holds 1 directorship: Medxen Biotech Private Limited (Director, since 09 Aug 2021, revenue ₹23.7 Lakh (FY 2025)).

Ankit Khaneja was first appointed on 09 Aug 2021 as Director at Medxen Biotech Private Limited.

The current boards of Ankit Khaneja's companies include Sakshi Arora (Medxen Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available